| 11/13/2024 | IG | New Issue: Gilead Sciences prices $3.5 billion of senior notes in four tranches
|
| 11/13/2024 | BKIG | Moody’s rates Gilead notes A3
|
| 11/13/2024 | IG | Gilead Sciences plans four-part offering of fixed-rate senior notes
|
| 9/7/2023 | IG | New Issue: Gilead Sciences sells $2 billion of senior notes due 2033, 2053
|
| 9/7/2023 | BKIG | Moody's assigns A3 to Gilead notes
|
| 9/7/2023 | IG | Gilead Sciences readies offering of three fixed-rate senior notes
|
| 5/18/2023 | BKIG | S&P revises Gilead outlook to positive
|
| 8/4/2022 | BKIG | Moody's alters Gilead outlook to stable
|
| 4/18/2022 | IG | S&P changes Gilead Sciences view to stable
|
| 10/27/2020 | BKIG | S&P cuts Gilead
|
| 9/25/2020 | IG | Market Commentary: BlackRock, Consumers Energy, EIB price; light supply forecast; Gilead, T-Mobile mixed
|
| 9/25/2020 | IG | Market Commentary: Morning Commentary: BlackRock plans high-grade bond tap; Gilead, B.A.T., T-Mobile mixed
|
| 9/24/2020 | IG | Market Commentary: High-grade supply thins; Avolon, Ontario Teachers price; bonds mixed; inflows decline
|
| 9/24/2020 | IG | Market Commentary: Morning Commentary: High-grade supply thins; Ontario Teachers on deck; Gilead mixed
|
| 9/24/2020 | IG | New Issue: Gilead Sciences details $7.25 billion of senior notes in seven parts
|
| 9/23/2020 | IG | Market Commentary: High-grade issuers flood primary; Gilead, Equinix, AerCap price; Ontario Teachers in pipeline
|
| 9/23/2020 | IG | New Issue: Gilead Sciences prices $6.75 billion of senior notes in six tranches
|
| 9/23/2020 | BKIG | Moody’s assigns A3 to Gilead notes
|
| 9/23/2020 | IG | Market Commentary: Morning Commentary: High-grade issuers deluge primary; Gilead, Equinix, AerCap on deck
|
| 9/23/2020 | IG | Gilead Sciences offers floating-, fixed-rate notes in six parts
|
| 9/22/2020 | BKIG | S&P rates Gilead notes, loans A
|
| 9/14/2020 | BKIG | S&P puts Gilead on watch
|
| 9/14/2020 | BKIG | Gilead eyes $6 billion new debt to finance acquisition of Immunomedics
|
| 9/14/2017 | IG | Market Commentary: High-grade supply robust; Gilead Sciences, BP, Scotiabank, Quebec, Kommuninvest price
|
| 9/14/2017 | IG | New Issue: Gilead Sciences prices $3 billion of senior notes in four tranches
|
| 9/14/2017 | BKIG | S&P: Gilead Sciences notes A
|
| 9/14/2017 | IG | Market Commentary: Morning Commentary: Scotiabank, Gilead Sciences market notes; Quebec, Kommuninvest to price
|
| 9/14/2017 | IG | Gilead to sell notes in four parts to fund Kite Pharma acquisition
|
| 8/28/2017 | IG | Moody's affirms Gilead at A3
|
| 8/28/2017 | BKBWIG | Gilead to take on bank debt, issue senior notes for Kite acquisition
|
| 9/19/2016 | IG | Market Commentary: Shire prices $12.1 billion; Hess, American Airlines, S&P tap market; credit spreads firm
|
| 9/19/2016 | IG | Market Commentary: Morning Commentary: Supply light; Gilead improves; Ingredion tightens; credit spreads firm
|
| 9/16/2016 | IG | Market Commentary: Active deal week forecast; Gilead Sciences, Cisco firm; 3M improves; credit spreads soften
|
| 9/16/2016 | IG | New Issue: Gilead Sciences details $5 billion five-tranche offer of senior notes
|
| 9/15/2016 | IG | Market Commentary: Gilead sells $5 billion; Freddie Mac, Pitney Bowes, CCL price; credit spreads tighten
|
| 9/15/2016 | IG | New Issue: Gilead Sciences prices $5 billion senior notes in five tranches
|
| 9/15/2016 | CVIG | S&P: Gilead Sciences notes A
|
| 9/15/2016 | CVIG | Moody’s gives A3 to Gilead notes
|
| 9/15/2016 | IG | Market Commentary: Morning Commentary: Primary supply heavy; Thermo Fisher, BP mostly flat; credit spreads firm
|
| 9/15/2016 | IG | Gilead Sciences to conduct offering of senior notes in five tranches
|
| 5/18/2016 | CVIG | Moody’s cuts Gilead Sciences to stable
|
| 9/11/2015 | IG | Market Commentary: Morning Commentary: Gilead Sciences mostly stronger in secondary market; Home Depot unchanged
|
| 9/10/2015 | IG | New Issue: Gilead Sciences details $10 billion six-part sale of senior notes
|
| 9/9/2015 | IG | New Issue: Gilead Sciences prices $10 billion of notes in six tranches
|
| 9/9/2015 | IG | Market Commentary: Primary surge continues; Gilead does $10 billion deal; Intel, Wal-Mart tighten
|
| 9/9/2015 | IG | Gilead Sciences launches $10 billion of senior notes in six tranches
|
| 9/9/2015 | CVIG | S&P rates Gilead notes A-
|
| 9/9/2015 | CVIG | Moody’s rates Gilead notes A3
|
| 9/9/2015 | IG | Gilead Sciences preparing to sell senior notes in six tranches
|
| 12/24/2014 | IG | Market Commentary: Investment-grade bond market activity slows; Amazon improves; credit spreads modestly better
|
| 12/24/2014 | IG | Market Commentary: Morning Commentary: Investment-grade bonds mixed in thin trade; Amazon long bonds firm
|
| 12/9/2014 | IG | Market Commentary: Morning Commentary: High-grade bonds soften; Morgan Stanley, Gilead Sciences notes ease
|
| 11/18/2014 | IG | Market Commentary: Morning Commentary: High-grade spreads firm as primary heats up; Gilead, Walgreens improve
|
| 11/14/2014 | IG | Market Commentary: Morning Commentary: Investment-grade credit spreads soft; Citigroup flat; Gilead tightens
|
| 11/12/2014 | IG | Market Commentary: Ten deals hit high-grade market following holiday; spreads flat; Eastman Chemical mixed
|
| 11/12/2014 | IG | New Issue: Gilead Sciences prices $4 billion of senior notes in three tranches
|
| 11/12/2014 | CVIG | S&P: Gilead Sciences notes A-
|
| 11/12/2014 | CVIG | Moody’s provides A3 to Gilead notes
|
| 11/12/2014 | IG | Gilead Sciences preparing to sell senior notes in three tranches
|
| 11/11/2014 | CVIG | Moody’s upgrades Gilead
|
| 3/5/2014 | IG | New Issue: Gilead Sciences details $4 billion sale of senior notes in three maturities
|
| 3/4/2014 | CVIG | S&P assigns Gilead debt A-
|
| 3/4/2014 | IG | Gilead Sciences to sell senior notes in three maturities
|
| 3/4/2014 | IG | New Issue: Gilead Sciences prices $4 billion senior notes in three maturities
|
| 3/4/2014 | IG | Market Commentary: Packed primary sees Gilead, RBC, Coca-Cola price; Aetna, Air Lease, Pitney Bowes firm
|
| 3/4/2014 | CVIG | Moody's rates Gilead's notes Baa1
|
| 12/9/2013 | CVIG | Moody's: Gilead view to positive
|
| 2/17/2012 | CVIG | Moody's says Gilead announcement is negative
|
| 12/7/2011 | IG | New Issue: Gilead Sciences gives terms of $3.7 billion note sale in four parts
|
| 12/6/2011 | CVIG | S&P assigns Gilead notes A-
|
| 12/6/2011 | CVIG | Moody's: Gilead notes Baa1
|
| 12/6/2011 | IG | New Issue: Gilead Sciences sells $3.7 billion three-, five-, 10-, 30-year notes
|
| 12/6/2011 | IG | Market Commentary: Gilead, HP, USAA Capital price debt as primary tone holds; HP, Gilead widen ahead of deals
|
| 11/21/2011 | CVIG | S&P affirms Gilead Sciences
|
| 11/21/2011 | CVIG | Moody's affirms Gilead
|
| 11/21/2011 | BKIG | Gilead Sciences to use loans, notes, cash for Pharmasset acquisition
|
| 6/13/2011 | CVIG | Moody's: Gilead unchanged
|
| 3/23/2011 | IG | Market Commentary: Verizon follows Sanofi with mega-deal, Gilead, Caterpillar price; new bonds firm 1 bp-2 bps
|
| 3/23/2011 | CVIG | S&P rates Gilead notes A-
|
| 3/23/2011 | CVIG | Moody's rates Gilead notes Baa1
|
| 3/23/2011 | CVIGPF | Gilead Sciences files automatic shelf for stock, preferreds and debt
|
| 3/23/2011 | IG | New Issue: Gilead Sciences sells $1 billion 4.5% 10-year notes at Treasuries plus 125 bps
|
